500013-36-5 Usage
Molecular structure
A chemical compound consisting of a piperazine ring, a carboxylic acid group, and a 4-[(3-hydroxyphenyl)methyl] side chain.
Usage
Primarily used as a building block in the synthesis of pharmaceuticals and other organic compounds.
Potential applications
May have applications in medicinal chemistry and drug design.
Modulating biological activity
The 1-piperazinecarboxylic acid moiety is known for its role in modulating biological activity.
Pharmacological properties
The 4-[(3-hydroxyphenyl)methyl] group may contribute to the compound's pharmacological properties.
Reactivity in chemical reactions
The 4-[(3-hydroxyphenyl)methyl] group may also affect the compound's reactivity in chemical reactions.
Versatility
1-piperazinecarboxylic acid, 4-[(3-hydroxyphenyl)methyl]is a versatile chemical for various scientific and industrial purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 500013-36-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,0,1 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 500013-36:
(8*5)+(7*0)+(6*0)+(5*0)+(4*1)+(3*3)+(2*3)+(1*6)=65
65 % 10 = 5
So 500013-36-5 is a valid CAS Registry Number.
500013-36-5Relevant articles and documents
Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library
?akelj, Simon,Frlan, Rok,Gobec, Stanislav,Hrast, Martina,Knez, Damijan,Kos, Janko,Pi?lar, Anja
, (2022/01/27)
The therapeutic indications for monoamine oxidases A and B (MAO-A and MAO-B) inhibitors that have emerged from biological studies on animal and cellular models of neurological and oncological diseases have focused drug discovery projects upon identifying
benzamide derivatives as oxytocin agonists and vasopressin antagonists
-
Page 30, (2010/02/08)
Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or Via receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
